Shattuck Labs (STTK) Cash from Operations (2019 - 2026)
Shattuck Labs' (STTK) quarterly Cash from Operations came in at 13424000.0 in Q1 2026, down 11.57% year-on-year from 15180222.56 in Q1 2025, and down 58.12% on a QoQ basis from 8490000.0 in Q4 2025.
Shattuck Labs (STTK) Cash from Operations (2019 - 2026) Analysis & Trends
Shattuck Labs (STTK) has 8 years of Cash from Operations data on file, last reported at 13424000.0 in Q1 2026.
- On a quarterly basis, Cash from Operations fell 11.57% year-over-year to 13424000.0 in Q1 2026; TTM through Mar 2026 was 41274000.0, a 26.8% increase from a year earlier, with the FY2025 full-year figure at 39882000.0, up 34.1% from the prior year.
- Cash from Operations for Q1 2026 stood at 13424000.0, down from 8490000.0 in the prior quarter.
- Over the last five years, Cash from Operations for STTK reached as high as 8490000.0 in Q4 2025 and fell as low as 28064000.0 in Q3 2022.
- Historically, Cash from Operations has averaged 17032176.47 across 5 years, with a median of 16316000.0 in 2022.
- Across the five-year window, Cash from Operations tumbled 137.41% in 2022 and surged 51.12% in 2025, its largest moves.
- Year by year, Cash from Operations stood at 23841000.0 in 2022, then rose by 18.55% to 19419000.0 in 2023, then gained by 10.55% to 17370000.0 in 2024, then jumped by 51.12% to 8490000.0 in 2025, then slumped by 58.12% to 13424000.0 in 2026.
- Per Business Quant data, the three most recent Cash from Operations figures were 13424000.0 in Q1 2026, 8490000.0 in Q4 2025, and 8929000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -19.59 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -2.49 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 201.34 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.43 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 1.08 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -354.17 Mn |
| 10 | Shattuck Labs | 831.66 Mn | 831.66 Mn | - | -13.42 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -13.42 Mn |
| Mar 31, 2026 | -13.42 Mn |
| Dec 31, 2025 | -8.49 Mn |
| Dec 31, 2025 | -8.49 Mn |
| Sep 30, 2025 | -8.93 Mn |
| Sep 30, 2025 | -8.93 Mn |
| Jun 30, 2025 | -10.43 Mn |
| Jun 30, 2025 | -10.43 Mn |
| Mar 31, 2025 | -12.03 Mn |
| Mar 31, 2025 | -12.03 Mn |
| Dec 31, 2024 | -17.37 Mn |
| Dec 31, 2024 | -17.37 Mn |
| Sep 30, 2024 | -16.07 Mn |
| Sep 30, 2024 | -16.07 Mn |
| Jun 30, 2024 | -10.92 Mn |
| Jun 30, 2024 | -10.92 Mn |
| Mar 31, 2024 | -16.16 Mn |
| Mar 31, 2024 | -16.16 Mn |
| Dec 31, 2023 | -19.42 Mn |
| Dec 31, 2023 | -19.42 Mn |